Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
39
TMCI Quote, Financials, Valuation and Earnings
Last price:
$5.81
Seasonality move
:
-5.27%
Day range:
$5.70 - $5.87
52-week range:
$4.54 - $10.79
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.73x
P/B ratio:
3.49x
Volume:
199.8K
Avg. volume:
303.8K
1-year change:
-30.77%
Market cap:
$368M
Revenue:
$209.4M
EPS (TTM):
-$0.85
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $57.4M | $94.4M | $141.8M | $187.1M | $209.4M | |
| Revenue Growth (YoY) | 45.54% | 64.59% | 50.22% | 31.92% | 11.89% | |
| Cost of Revenues | $12.5M | $16.9M | $25.5M | $35.2M | $41.1M | |
| Gross Profit | $44.9M | $77.5M | $116.3M | $151.9M | $168.3M | |
| Gross Profit Margin | 78.26% | 82.11% | 82% | 81.2% | 80.37% | |
| R&D Expenses | $5.8M | $10.2M | $13.6M | $15.4M | $20.6M | |
| Selling, General & Admin | $38.2M | $83.8M | $137.6M | $187.9M | $203.4M | |
| Other Inc / (Exp) | -- | $1K | -$4.9M | $342K | $324K | |
| Operating Expenses | $44M | $94M | $151.2M | $203.4M | $224M | |
| Operating Income | $855K | -$16.5M | -$34.8M | -$51.4M | -$55.7M | |
| Net Interest Expenses | $4.5M | $4M | $3.1M | -- | $379K | |
| EBT. Incl. Unusual Items | -$3.7M | -$20.6M | -$42.8M | -$49.5M | -$55.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$3.7M | -$20.6M | -$42.8M | -$49.5M | -$55.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$3.7M | -$20.6M | -$42.8M | -$49.5M | -$55.7M | |
| Basic EPS (Cont. Ops) | -$0.10 | -$0.43 | -$0.77 | -$0.81 | -$0.90 | |
| Diluted EPS (Cont. Ops) | -$0.10 | -$0.43 | -$0.77 | -$0.81 | -$0.90 | |
| Weighted Average Basic Share | $43.9M | $48.4M | $55.3M | $60.9M | $62.1M | |
| Weighted Average Diluted Share | $43.9M | $48.4M | $55.3M | $60.9M | $62.1M | |
| EBITDA | $2.1M | -$15.8M | -$36.3M | -$39M | -$42.1M | |
| EBIT | $855K | -$16.5M | -$38.4M | -$44.4M | -$50.5M | |
| Revenue (Reported) | $57.4M | $94.4M | $141.8M | $187.1M | $209.4M | |
| Operating Income (Reported) | $855K | -$16.5M | -$34.8M | -$51.4M | -$55.7M | |
| Operating Income (Adjusted) | $855K | -$16.5M | -$38.4M | -$44.4M | -$50.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $18.7M | $29M | $42.2M | $51.1M | $52.6M | |
| Revenue Growth (YoY) | 66.2% | 55.27% | 45.27% | 21.12% | 2.86% | |
| Cost of Revenues | $3.3M | $5.1M | $8M | $10.1M | $10.7M | |
| Gross Profit | $15.4M | $23.9M | $34.2M | $41M | $41.9M | |
| Gross Profit Margin | 82.22% | 82.34% | 80.95% | 80.19% | 79.69% | |
| R&D Expenses | $1.9M | $3.1M | $3.4M | $5.3M | $5.6M | |
| Selling, General & Admin | $14.9M | $29M | $44.5M | $54.7M | $51.9M | |
| Other Inc / (Exp) | -- | $2K | $128K | $74K | $130K | |
| Operating Expenses | $16.8M | $32M | $47.9M | $59.9M | $57.5M | |
| Operating Income | -$1.4M | -$8.1M | -$13.8M | -$19M | -$15.6M | |
| Net Interest Expenses | $1M | $942K | -- | -- | $470K | |
| EBT. Incl. Unusual Items | -$2.4M | -$9M | -$13.5M | -$18.7M | -$15.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$2.4M | -$9M | -$13.5M | -$18.7M | -$15.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$2.4M | -$9M | -$13.5M | -$18.7M | -$15.9M | |
| Basic EPS (Cont. Ops) | -$0.05 | -$0.16 | -$0.23 | -$0.30 | -$0.25 | |
| Diluted EPS (Cont. Ops) | -$0.05 | -$0.16 | -$0.23 | -$0.30 | -$0.25 | |
| Weighted Average Basic Share | $50.5M | $54.8M | $58.7M | $61.8M | $62.7M | |
| Weighted Average Diluted Share | $50.5M | $54.8M | $58.7M | $61.8M | $62.7M | |
| EBITDA | -$1.3M | -$7.8M | -$11.2M | -$15.5M | -$12.2M | |
| EBIT | -$1.4M | -$8.1M | -$12.2M | -$17.4M | -$14.6M | |
| Revenue (Reported) | $18.7M | $29M | $42.2M | $51.1M | $52.6M | |
| Operating Income (Reported) | -$1.4M | -$8.1M | -$13.8M | -$19M | -$15.6M | |
| Operating Income (Adjusted) | -$1.4M | -$8.1M | -$12.2M | -$17.4M | -$14.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $64.8M | $104.8M | $155M | $196M | $210.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $13.4M | $18.7M | $28.4M | $37.3M | $41.6M | |
| Gross Profit | $51.4M | $86.1M | $126.5M | $158.8M | $169.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $6.3M | $11.4M | $13.9M | $17.3M | $20.9M | |
| Selling, General & Admin | $44.5M | $97.9M | $153.1M | $198.1M | $200.6M | |
| Other Inc / (Exp) | -- | $2K | -$4.8M | $288K | $380K | |
| Operating Expenses | $50.8M | $109.3M | $167.1M | $215.4M | $221.5M | |
| Operating Income | $652K | -$23.2M | -$40.5M | -$56.6M | -$52.3M | |
| Net Interest Expenses | $5.1M | $4M | $1.9M | -- | $1.1M | |
| EBT. Incl. Unusual Items | -$4.5M | -$27.2M | -$47.2M | -$54.7M | -$53M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$4.5M | -$27.2M | -$47.2M | -$54.7M | -$53M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$4.5M | -$27.2M | -$47.2M | -$54.7M | -$53M | |
| Basic EPS (Cont. Ops) | -$0.11 | -$0.50 | -$0.84 | -$0.88 | -$0.85 | |
| Diluted EPS (Cont. Ops) | -$0.11 | -$0.50 | -$0.84 | -$0.88 | -$0.85 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $1.7M | -$22.3M | -$39.8M | -$43.2M | -$38.8M | |
| EBIT | $656K | -$23.2M | -$42.5M | -$49.6M | -$47.7M | |
| Revenue (Reported) | $64.8M | $104.8M | $155M | $196M | $210.8M | |
| Operating Income (Reported) | $652K | -$23.2M | -$40.5M | -$56.6M | -$52.3M | |
| Operating Income (Adjusted) | $656K | -$23.2M | -$42.5M | -$49.6M | -$47.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $18.7M | $29M | $42.2M | $51.1M | $52.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3.3M | $5.1M | $8M | $10.1M | $10.7M | |
| Gross Profit | $15.4M | $23.9M | $34.2M | $41M | $41.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $1.9M | $3.1M | $3.4M | $5.3M | $5.6M | |
| Selling, General & Admin | $14.9M | $29M | $44.5M | $54.7M | $51.9M | |
| Other Inc / (Exp) | -- | $2K | $128K | $74K | $130K | |
| Operating Expenses | $16.8M | $32M | $47.9M | $59.9M | $57.5M | |
| Operating Income | -$1.4M | -$8.1M | -$13.8M | -$19M | -$15.6M | |
| Net Interest Expenses | $1M | $942K | -- | -- | $470K | |
| EBT. Incl. Unusual Items | -$2.4M | -$9M | -$13.5M | -$18.7M | -$15.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$2.4M | -$9M | -$13.5M | -$18.7M | -$15.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$2.4M | -$9M | -$13.5M | -$18.7M | -$15.9M | |
| Basic EPS (Cont. Ops) | -$0.05 | -$0.16 | -$0.23 | -$0.30 | -$0.25 | |
| Diluted EPS (Cont. Ops) | -$0.05 | -$0.16 | -$0.23 | -$0.30 | -$0.25 | |
| Weighted Average Basic Share | $50.5M | $54.8M | $58.7M | $61.8M | $62.7M | |
| Weighted Average Diluted Share | $50.5M | $54.8M | $58.7M | $61.8M | $62.7M | |
| EBITDA | -$1.3M | -$7.8M | -$11.2M | -$15.5M | -$12.2M | |
| EBIT | -$1.4M | -$8.1M | -$12.2M | -$17.4M | -$14.6M | |
| Revenue (Reported) | $18.7M | $29M | $42.2M | $51.1M | $52.6M | |
| Operating Income (Reported) | -$1.4M | -$8.1M | -$13.8M | -$19M | -$15.6M | |
| Operating Income (Adjusted) | -$1.4M | -$8.1M | -$12.2M | -$17.4M | -$14.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $18.1M | $105.8M | $19.5M | $13M | $11.4M | |
| Short Term Investments | -- | -- | $61.8M | $110.2M | $64.3M | |
| Accounts Receivable, Net | $14.5M | $18.6M | $29.2M | $38.1M | $40.8M | |
| Inventory | $7.8M | $10.6M | $19.3M | $29.2M | $39.3M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $593K | $3M | $3.6M | $7.9M | $5.7M | |
| Total Current Assets | $41M | $138M | $133.4M | $198.4M | $161.4M | |
| Property Plant And Equipment | $829K | $2.8M | $25.5M | $31.6M | $34.4M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | $12.8M | $12.8M | |
| Other Intangibles | -- | -- | -- | $9M | $8.1M | |
| Other Long-Term Assets | -- | -- | $146K | $146K | $407K | |
| Total Assets | $41.8M | $140.8M | $159M | $251.9M | $217.1M | |
| Accounts Payable | $2.3M | $4.1M | $8.7M | $11.8M | $10.5M | |
| Accrued Expenses | $5.4M | $9.7M | $13.6M | $17.9M | $15.2M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $339K | $1.4M | $413K | |
| Other Current Liabilities | -- | -- | -- | $3M | $97K | |
| Total Current Liabilities | $11.6M | $18.2M | $30.2M | $45M | $34.9M | |
| Long-Term Debt | $29.2M | $29.4M | $52.7M | $53M | $53.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $41M | $47.7M | $98.5M | $114M | $104.2M | |
| Common Stock | $8M | $45K | $55K | $62K | $62K | |
| Other Common Equity Adj | -- | -- | -$27K | $163K | $97K | |
| Common Equity | -$7.2M | $93.1M | $60.5M | $137.9M | $112.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $776K | $93.1M | $60.5M | $137.9M | $112.9M | |
| Total Liabilities and Equity | $41.8M | $140.8M | $159M | $251.9M | $217.1M | |
| Cash and Short Terms | $18.1M | $105.8M | $81.3M | $123.2M | $75.7M | |
| Total Debt | $31M | $29.4M | $52.7M | $53M | $53.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $16.2M | $98.5M | $29.6M | $9.3M | $13.4M | |
| Short Term Investments | -- | -- | $141M | $100.7M | $62.7M | |
| Accounts Receivable, Net | $10.8M | $16M | $25.4M | $30.1M | $31.1M | |
| Inventory | $7.4M | $11.1M | $22.5M | $35.9M | $37.9M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $2.1M | $1.7M | $4.6M | $11.4M | $4.3M | |
| Total Current Assets | $36.5M | $127.3M | $223.1M | $187.4M | $149.4M | |
| Property Plant And Equipment | $929K | $19.1M | $25.8M | $33.6M | $35.4M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | $12.8M | $12.8M | |
| Other Intangibles | -- | -- | -- | $8.8M | $7.8M | |
| Other Long-Term Assets | -- | $134K | $215K | $146K | $387K | |
| Total Assets | $37.4M | $146.5M | $249.2M | $242.7M | $205.8M | |
| Accounts Payable | $1.3M | $3.4M | $5.1M | $21.1M | $13.2M | |
| Accrued Expenses | $5.5M | $7.4M | $13.9M | $13.1M | $12.5M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $45K | |
| Current Portion Of Capital Lease Obligations | -- | $435K | $1.1M | $864K | $2M | |
| Other Current Liabilities | -- | -- | -- | $158K | $154K | |
| Total Current Liabilities | $8.6M | $15.4M | $23.3M | $47M | $33.2M | |
| Long-Term Debt | $29.2M | $29.4M | $52.8M | $53.1M | $53.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $38.1M | $59.7M | $91.6M | $116.3M | $100.5M | |
| Common Stock | $8M | $46K | $61K | $62K | $63K | |
| Other Common Equity Adj | -- | -- | -$56K | $69K | $57K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$684K | $86.8M | $157.6M | $126.4M | $105.3M | |
| Total Liabilities and Equity | $37.4M | $146.5M | $249.2M | $242.7M | $205.8M | |
| Cash and Short Terms | $16.2M | $98.5M | $170.7M | $110M | $76.1M | |
| Total Debt | $29.2M | $29.4M | $52.8M | $53.1M | $53.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$3.7M | -$20.6M | -$42.8M | -$49.5M | -$55.7M | |
| Depreciation & Amoritzation | $1.2M | $685K | $2.1M | $5.4M | $8.4M | |
| Stock-Based Compensation | $919K | $3.4M | $8.1M | $17.4M | $30.6M | |
| Change in Accounts Receivable | -$4.3M | -$4.2M | -$11M | -$9.3M | -$5.7M | |
| Change in Inventories | -$2.3M | -$2.7M | -$8.8M | -$9.8M | -$10M | |
| Cash From Operations | -$4.5M | -$17.2M | -$30.6M | -$34.6M | -$37.2M | |
| Capital Expenditures | $1.1M | $2.7M | $14.8M | $11.5M | $11.6M | |
| Cash Acquisitions | -- | -- | -- | -$20M | -- | |
| Cash From Investing | -$1.1M | -$2.7M | -$76.5M | -$81.3M | $35.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $31.3M | -- | $53.5M | -- | -- | |
| Long-Term Debt Repaid | -$20M | -$1.8M | -$33.9M | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$179K | -- | -$989K | -$13K | -$268K | |
| Cash From Financing | $11.5M | $107.7M | $20.8M | $109.4M | $160K | |
| Beginning Cash (CF) | $12.1M | $18.1M | $105.8M | $19.5M | $13M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $5.9M | $87.8M | -$86.4M | -$6.5M | -$1.6M | |
| Ending Cash (CF) | $18.1M | $105.8M | $19.5M | $13M | $11.4M | |
| Levered Free Cash Flow | -$5.6M | -$19.9M | -$45.5M | -$46M | -$48.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$2.4M | -$9M | -$13.5M | -$18.7M | -$15.9M | |
| Depreciation & Amoritzation | $117K | $334K | $924K | $1.9M | $2.5M | |
| Stock-Based Compensation | $402K | $1.4M | $2.7M | $7.4M | $8.7M | |
| Change in Accounts Receivable | $3.8M | $2.5M | $3.8M | $7.8M | $9.3M | |
| Change in Inventories | $478K | -$551K | -$3.2M | -$6.6M | $1.3M | |
| Cash From Operations | -$446K | -$7.2M | -$17.3M | -$7.2M | $4.2M | |
| Capital Expenditures | $196K | $1.5M | $1.5M | $3.9M | $3.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$196K | -$1.5M | -$80.5M | $3.8M | -$1.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.8M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$237K | -$401K | |
| Cash From Financing | -$1.2M | $1.4M | $107.9M | -$185K | -$282K | |
| Beginning Cash (CF) | $18.1M | $105.8M | $19.5M | $13M | $11.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.9M | -$7.4M | $10.1M | -$3.6M | $2M | |
| Ending Cash (CF) | $16.2M | $98.5M | $29.6M | $9.3M | $13.4M | |
| Levered Free Cash Flow | -$642K | -$8.7M | -$18.7M | -$11.1M | $655K | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$4.5M | -$27.2M | -$47.2M | -$54.7M | -$53M | |
| Depreciation & Amoritzation | $1M | $902K | $2.7M | $6.3M | $9M | |
| Stock-Based Compensation | $1.1M | $4.4M | $9.4M | $22.1M | $31.9M | |
| Change in Accounts Receivable | -$4.3M | -$5.5M | -$9.8M | -$5.3M | -$4.2M | |
| Change in Inventories | -$420K | -$3.8M | -$11.4M | -$13.3M | -$2.1M | |
| Cash From Operations | -$4M | -$24M | -$40.7M | -$24.5M | -$25.7M | |
| Capital Expenditures | $591K | $4M | $14.8M | $13.9M | $11.2M | |
| Cash Acquisitions | -- | -- | -- | -$20M | -- | |
| Cash From Investing | -$591K | -$4M | -$155.5M | $2.9M | $29.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$21.8M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$432K | |
| Cash From Financing | $10.3M | $110.2M | $127.3M | $1.3M | $63K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $5.6M | $82.3M | -$68.9M | -$20.3M | $4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$4.6M | -$28M | -$55.5M | -$38.4M | -$37M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$2.4M | -$9M | -$13.5M | -$18.7M | -$15.9M | |
| Depreciation & Amoritzation | $117K | $334K | $924K | $1.9M | $2.5M | |
| Stock-Based Compensation | $402K | $1.4M | $2.7M | $7.4M | $8.7M | |
| Change in Accounts Receivable | $3.8M | $2.5M | $3.8M | $7.8M | $9.3M | |
| Change in Inventories | $478K | -$551K | -$3.2M | -$6.6M | $1.3M | |
| Cash From Operations | -$446K | -$7.2M | -$17.3M | -$7.2M | $4.2M | |
| Capital Expenditures | $196K | $1.5M | $1.5M | $3.9M | $3.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$196K | -$1.5M | -$80.5M | $3.8M | -$1.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.8M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$237K | -$401K | |
| Cash From Financing | -$1.2M | $1.4M | $107.9M | -$185K | -$282K | |
| Beginning Cash (CF) | $18.1M | $105.8M | $19.5M | $13M | $11.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.9M | -$7.4M | $10.1M | -$3.6M | $2M | |
| Ending Cash (CF) | $16.2M | $98.5M | $29.6M | $9.3M | $13.4M | |
| Levered Free Cash Flow | -$642K | -$8.7M | -$18.7M | -$11.1M | $655K | |
Get TMCI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TMCI
Sector
P/E ratio
--
23.88x
PEG ratio
-0.73x
0.00x
P/B ratio
3.49x
1.80x
Price / LTM sales
1.73x
1.65x
Growth Metrics
TMCI
Sector
Revenue growth
2.86%
4.06%
Earnings growth
--
7.46%
Revenue (5-year growth)
39.65%
8.01%
Earnings forecast
-$0.29
-$0.20
Profitability
TMCI
Sector
Profitability FY 2024
$168.3M
$47.5M
Return on invested capital
-32%
-16.26%
Return on assets
-23.98%
-13.27%
Return on equity
-47.17%
-18.61%
Earnings Date
Last Earnings Date
May
8
Next Earnings Date
Aug
6
Estimated Next Earnings Date
Aug
7
Balance Sheet
TMCI
Sector
Total cash
$76.1M
$35.5M
Short term investments
$64.3M
$29.7M
Total assets
$217.1M
$106.9M
Long term debt
$53.4M
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
